Picard Medical (PMI) Cash & Equivalents (2024 - 2026)

Picard Medical (PMI) has 3 years of Cash & Equivalents data on file, last reported at $121000.0 in Q1 2026.

• Quarterly Cash & Equivalents changed N/A year-over-year to $121000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $121000.0 (changed N/A YoY) and the FY2025 annual result came in at $7.5 million, up 7661.46% from the prior year.
• Cash & Equivalents fell to $121000.0 in Q1 2026, from $7.5 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $7.5 million in Q4 2025 to a low of $96000.0 in Q4 2024.
• A 3-year average of $2.2 million and a median of $410000.0 in 2025 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 7661.46% in 2025, down 7661.46% in 2025.
• Tracing PMI's Cash & Equivalents over 3 years: stood at $96000.0 in 2024, then soared by 7661.46% to $7.5 million in 2025, then sank by 98.38% to $121000.0 in 2026.
• The last three Cash & Equivalents figures came in at $121000.0 (Q1 2026), $7.5 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.